Cited by 83Endometriosis Research and TreatmentEstrogen and related hormone effectsEpigenetics and DNA Methylation

An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells

Open access
Izawa, Masao, Harada, Tasuku, Taniguchi, Fuminori, Ohama, Yoko, Takenaka, Yasuko, Terakawa, Naoki·2008·Fertility and Sterility

Abstract

Objective To examine the molecular basis of aromatase expression in stromal cell culture from endometriotic chocolate cysts.Design Prospective study.Setting Department of Obstetrics and Gynecology and Department of Biosignaling, Tottori University, Yonago Japan.Patient(s) Thirty women, selected randomly, who underwent laparoscopy (n = 18) or laparotomy (n = 12).Intervention(s) Endometrial and endometriotic stromal cells were obtained from the uterus and chocolate cyst lining of the ovary.Main outcome measure(s) Estradiol concentrations in the culture media were measured by means of enzyme immunoassay. Aromatase expression was examined by quantitative real-time polymerase chain reaction. Promoter usage was examined using unique exon I (PII, I.1, I.3, I.4, I.5, and I.6) and exon II primers. To determine the effect of 5-aza-deoxycytidine on endometrial stromal cells, the cells were treated with the agent for 96 hours.Result(s) Endometriotic cells secreted a marginal level of estradiol into the culture media, but adding testosterone to the culture produced a pronounced level of estradiol. In endometrial cells, estradiol production was far less efficient than in endometriotic cells even after adding testosterone. Real-time polymerase chain reaction analyses demonstrated the up-regulation of aromatase messenger RNA (mRNA) expression in endometriotic cells. Three proximal promoters, PII, 1.3, and 1.6, drove mRNA expression. In endometrial cells where a marginal level of aromatase mRNA expression was observed, the same promoters as those in the endometriotic cells were used. To determine the role of epigenetic modification of aromatase gene expression in endometriotic cells, endometrial cells were treated with 5-aza-deoxycytidine, which markedly enhanced aromatase mRNA expression, depending on the same proximal promoters as those in endometriotic cells.Conclusion(s) An epigenetic disorder may play a role in the pathophysiology of endometriosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2007.03.078

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The promoter of the gene coding for P450 aromatase is hypermethylated and silenced in normal endometrial stromal cells.

    “In stark contrast to endometriotic stromal cells, in fact, the promoter of the gene coding for P450 aromatase is hypermethylated in normal endometrial stromal cells, and thus silenced [67,68].”

    From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [67]

  • The difference in E2 production between HESCs and ESCLs is consistent with what has been documented previously.

    “The difference in E2 production between HESCs and ESCLs is consistent with what have been documented previously41–45.”
  • The result of 4.5 fold increase in estrogen production in endometriotic stromal cells stimulated with activated platelets vs. those unstimulated is remarkably close to the reported fold increase found between testosterone-added endometriotic and endometrial stromal cells (4.1 for follicular phase and 4.5 for luteal phase).

    “The result of 4.5 fold increase in estrogen production in endometriotic stromal cells stimulated with activated platelets vs. those unstimulated is remarkably close to the reported fold increase found between testosterone-added endometriotic and endometrial stromal cells (4.1 for follicular phase and 4.5 for luteal phase)41.”
  • Normal endometrial stromal cells only produce negligible levels of estrogens likely due to a silenced aromatase because of hypermethylation.

    “While normal endometrial stromal cells only produce negligible levels of estrogens41 likely due to a silenced aromatase because of hypermethylation41,42”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 83

Authors
Izawa, M., Harada, T., Taniguchi, F., Ohama, Y., Takenaka, Y., & Terakawa, N.
Affiliations
Tottori University (JP)
Corresponding author
Harada, Tasuku
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2008-05
Volume
89
Issue
5
Pages
1390-1396
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2038692288
Cited by
83
References
25
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 1 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 4
FWCI
5.50
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
endometriosis, aromatase, endometriotic stromal cells, endometrial stromal cells, epigenetic regulation, promoter usage, estradiol production, 5-aza-deoxycytidine, DNA methylation, endometrioma, aromatase mRNA expression
MeSH terms
Decitabine, Aromatase, Azacitidine, Cells, Cultured, Endometriosis, Estradiol, Female, Humans, Ovarian Diseases, Promoter Regions, Genetic, RNA, Messenger, Uterine Diseases, Gene Expression Regulation, Enzymologic, Stromal Cells, CpG Islands, DNA Methylation, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review